The recent 510(k) clearance of the Vanquish™ Water Vapor Ablation System by the U.S. Food and Drug Administration marks an interesting development in the evolving field of focal therapy for prostate cancer. Developed by Francis Medical, the technology introduces a familiar energy source—water vapor—but applies it in a new oncologic...
